From drug screening to critical assay reagents and as targeted therapeutics, aptamers are increasingly being employed across the discovery and development pipeline. Despite the large catalogues of antibodies, aptamers and…
DNA day on April 25th, celebrates major scientific achievements concerning DNA, in particular the completion of the Human Genome Project in 2003 and the discovery of DNA’s double helix…
In the age of the reproducibility crisis, working with affinity tools that offer the highest batch consistency is critical for the development of robust assays and reliable data. Aptamers,…
Gene therapy is the future for the treatment of several, often life-threatening conditions. Several gene therapy assets are currently under trial targeting cancers, sensory organs, blood disease, and rare…
Novel diagnostic platforms are bringing possibilities for improved patient care and reduced healthcare costs. We spoke with Dr Edgar Goluch, the CEO and founder of QSM Diagnostics,
In the recently published paper in Talenta from Dr Mark Platt and the team at Loughborough University, they demonstrate a novel approach for aptamer biosensors to detect…
Detecting and quantifying small molecule analytes can be difficult. Our specially designed displacement approach allows us to select aptamers that can directly be used in various biosensor platforms for…
Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…
AptaBlot – increasing the utility of Western Blotting Western Blotting is a powerful technique used to detect and identify proteins. Antibodies have traditionally been used as the detection…
Flow Cytometry Flow Cytometry is a technique used to identify biomarkers on cell surfaces and intracellular molecules. Most flow cytometers use fluorescently labelled antibodies to differentiate between cells…
